
    
      Goals of this study include:

        -  Explore which circulating endocrine markers or endocrine related markers have the best
           potential to predict clinical response to abiraterone acetate in CRPC patients

        -  Explore the utility of microRNA, circulating DNA and exosome analyses in complementing
           the previous objective
    
  